Rhenman & Partners Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.37M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $3.25M | Sell |
|
|||||
|
2024
Q2 | $7.42M | Sell |
|
|||||
|
2024
Q1 | $9.75M | Buy |
|
|||||
|
2023
Q4 | $5.21M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2.59M | Sell |
|
|||||
|
2019
Q2 | $3.9M | Buy |
|
|||||
|
2019
Q1 | $3.41M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $524K | Buy |
|